Evolution of some liver function markers after treatment in patients with schizophrenia and bipolar disorder

por Sellami, S., Maalej, M., Ayadi, M., Naifar, M., Maalej, M., Ayadi, F.
Publicado 2023

C-reactive protein levels and cognitive functions in patients with bipolar disorder

por Elleuch, O., Maalej, M., Guidara, W., Naifar, M., Maalej, M., Ayadi, F.
Publicado 2023

Alteration of plasma phospholipids distinguish schizophrenic patients from controls: A targeted metabolomics study

por Naifar, M., Abdellah, T., Franklin, D., Carine, P., Plichet, T., Maalej, M., Guidara, W., Maalej, M., Ayadi, F., Bekri, S.
Publicado 2023

Alteration of plasma phospholipids distinguish schizophrenic patients from controls: A targeted metabolomics study

por Naifar, M., Tebani, A., Ducatez, F., Pilon, C., Plichet, T., Maalej, M., Guidara, W., Maalej, M., AYADI, F., Bekri, S.
Publicado 2023

Association between oxidative stress and altered cholesterol metabolism in patients with Bipolar Disorder

por Guidara, W., Messedi, M., Naifar, M., Ben Hassen, K., Bonnefont-Rousselot, D., Lamari, F., Maalej, M., Maalej, M., Makni-Ayadi, F.
Publicado 2023

Thermogenic and hemodynamic effects of ingesting a pre-workout supplement with and without synephrine

por Jung, YP, Goodenough, C, Cho, M, O’Connor, A, Dalton, R, Levers, K, Galvan, E, Barringer, N, Ayadi, F, Carter, J, Koozechian, M, Simbo, S, Reyes, A, Sanchez, B, Coletta, A, Rasmussen, C, Kreider, R
Publicado 2014

Effects of ingesting a pre-workout supplement with and without synephrine on cognitive function, perceptions of readiness to perform, and exercise performance

por Cho, M, Jung, YP, Goodenough, C, O’Connor, A, Dalton, R, Levers, K, Galvan, E, Barringer, N, Ayadi, F, Carter, J, Koozechian, M, Simbo, S, Reyes, A, Sanchez, B, Coletta, A, Rasmussen, C, Kreider, R
Publicado 2014